课题基金 / 基金详情

LILRB4/CD1d信号通路作为免疫检查点调控PD-L1+Treg亚群介导的T细胞耗竭机制研究

批准号:
81972200
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
伍思培
依托单位:
学科分类:
肿瘤免疫治疗
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
伍思培

项目摘要

结项摘要

项目成果

相似基金

相关文献

中文摘要
LILRB4蛋白含有免疫检查点共有的ITIMs基序,但其调控T细胞耗竭的机制尚不清楚。我们前期研究发现,LILRB4/CD1D基因的表达与肺癌PD-L1+Tregs的浸润密切相关。蛋白互作网络分析发现LILRB4与CD1d有相互关系。免疫共沉淀验证LILRB4可以直接绑定CD1d,目前未见有关LILRB4/CD1d作为免疫检查点的报道。据此我们提出假说:LILRB4/CD1D作为免疫检查点参与PD-L1+Tregs亚群对T细胞耗竭的调控作用。本课题拟从分子,细胞,组织以及动物水平等多层次明确LILRB4/CD1D参与PD-L1+Tregs免疫调控;并探讨其调控机制;确定LILRB4/CD1D对T细胞免疫耗竭的调控;揭示LILRB4/CD1D通过PD-L1+Tregs调控T细胞免疫应答的作用机制。本项目将提出LILRB4/CD1D作为检查点调控T细胞耗竭这一新视点,为肺癌免疫治疗提供新思路。
英文摘要
LILRB4 protein contains the ITIMs motif shared by immune checkpoints, but the mechanism of regulation in T cell exhausted is unclear. Our previous studies have found that the expression of LILRB4/CD1D gene was related to the infiltration of PD-L1+Tregs in lung cancer. The protein-protein interaction net work analysis showed that LILRB4 was correlated with CD1d. Immunocoprecipitation analysis showed that LILRB4 could binding CD1d. There was no report about LILRB4/CD1d as an immune checkpoint. Therefore, we hypothesize that LILRB4/CD1D as an immune checkpoint in the regulation of T cell depletion by PD-L1+Tregs subpopulation. This project will clarify the role of LILRB4/CD1D in the immune regulation of PD-L1+Tregs at molecular, cellular, tissue and animal levels, and to explore its regulatory mechanism, determine the regulation of LILRB4/CD1D on T cell immune exhaustion, and reveal the mechanism of LILRB4/CD1D regulating T cell immune response through PD-L1+Tregs. This project will present LILRB4/CD1D as a checkpoint to regulate T cell exhausted, which will provide a new idea for immunotherapy of lung cancer.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI: 10.1002/cam4.4925
发表时间: 2023-01
期刊: CANCER MEDICINE
影响因子: 4
作者: [Tian, Hong-xia, Chen, Zhi-hong, Jie, Guang-Ling, Wang, Zhen, Yan, Hong-hong, Wu, Si-pei, Zhang, Shui-lian, Lu, Dan-xia, Zhang, Xu-chao, Wu, Yi-long]
通讯作者: Wu, Yi-long
DOI: 10.1002/1878-0261.13439
发表时间: 2023-08
期刊: MOLECULAR ONCOLOGY
影响因子: 6.6
作者: [Tu, Hai-Yan, Yin, Kai, Zhao, Xiaotian, Ke, E-E, Wu, Si-Pei, Li, Yang-Si, Zheng, Mei-Mei, Liu, Si-Yang Maggie, Xu, Chong-Rui, Sun, Yue-Li, Lin, Jia-Xin, Bai, Xiao-Yan, Zhang, Yi-Chen, Zhou, Qing, Yang, Jin-Ji, Zhong, Wen-Zhao, Wang, Bing-Chao, Zhang, Xu-Chao, Zhu, Dongqin, Yang, Lingling, Ou, Qiuxiang, Wu, Yi-Long]
通讯作者: Wu, Yi-Long
国内基金
海外基金